Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-052964

President & CEO sold 68,444 shares at an average $116.68 ($7,986,219)

  • President & CEO acquired 56,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hassanein Waleed H President & CEO 2024-05-01 Option exercise 10b5-1 +56,000 $13.28 $743,680 130,087 D: show line 1 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −2,685 $105.56 $283,429 127,402 D: show line 2 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −91 $106.51 $9,692 127,311 D: show line 3 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −424 $107.57 $45,610 126,887 D: show line 4 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −6,800 $110.00 $748,000 120,087 D: show line 5 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −23,500 $114.17 $2,682,995 96,587 D: show line 6 in the form
Hassanein Waleed H President & CEO 2024-05-01 Sale 10b5-1 −22,500 $120.25 $2,705,625 74,087 D: show line 7 in the form
Hassanein Waleed H President & CEO 2024-05-02 Sale 10b5-1 −6,140 $120.64 $740,730 67,947 D: show line 8 in the form
Hassanein Waleed H President & CEO 2024-05-02 Sale 10b5-1 −6,222 $122.16 $760,080 61,725 D: show line 9 in the form
Hassanein Waleed H President & CEO 2024-05-02 Sale 10b5-1 −82 $122.67 $10,059 61,643 D: show line 10 in the form
Open-market sales · 68,444 sh · avg $116.68 · $7,986,219

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hassanein Waleed H President & CEO 2024-05-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −56,000 178,000 D: show line 11 in the form
Loading xslF345X05/ownership.xml…